Comments by "Terje Oseberg" (@terjeoseberg990) on "Antiviral game changer" video.

  1. Isn’t Molnupiravir practically the same as Favipiravir, but 100 times more expensive so big pharma can get rich?
    2
  2. They’re using Favipiravir in India and Turkey.
    1
  3. Isn’t it unethical to not conduct a clinical trial with an existing drug that’s already being used by millions in India and Turkey so we already know it’s safe? And whats so special about a multinational clinical trial with only around 1,000 participants? That sounds just as sh!tty as the Ivermectin trials. They should have had at least 30,000 participants like the vaccine trials.
    1
  4. India needs to conduct their own clinical trial comparing the efficacy of Favipiravir, Molnupiravir, and Ivermectin. They could have 150,000 participants with 50,000 per arm. My guess is that they’ll find that Favipiravir and Molnupiravir are the same and Ivermectin is ineffective.
    1